DGS Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $622K | Buy |
3,501
+140
| +4% | +$24.9K | 0.16% | 130 |
|
|
2024
Q3 | $664K | Buy |
3,361
+371
| +12% | +$73.3K | 0.18% | 118 |
|
|
2024
Q2 | $513K | Sell |
2,990
-289
| -9% | -$49.6K | 0.14% | 135 |
|
|
2024
Q1 | $597K | Buy |
3,279
+814
| +33% | +$148K | 0.17% | 115 |
|
|
2023
Q4 | $382K | Sell |
2,465
-170
| -6% | -$26.3K | 0.15% | 134 |
|
|
2023
Q3 | $393K | Buy |
2,635
+228
| +9% | +$34K | 0.19% | 123 |
|
|
2023
Q2 | $324K | Sell |
2,407
-3
| -0.1% | -$404 | 0.16% | 142 |
|
|
2023
Q1 | $384K | Sell |
2,410
-152
| -6% | -$24.2K | 0.21% | 105 |
|
|
2022
Q4 | $414K | Buy |
2,562
+130
| +5% | +$21K | 0.27% | 91 |
|
|
2022
Q3 | $326K | Buy |
2,432
+193
| +9% | +$25.9K | 0.22% | 104 |
|
|
2022
Q2 | $343K | Buy |
2,239
+586
| +35% | +$89.8K | 0.28% | 86 |
|
|
2022
Q1 | $268K | Buy |
+1,653
| New | +$268K | 0.16% | 138 |
|